- Home
- BNTX vs KEYS Comparison
BNTX vs KEYS Comparison
Compare BNTX & KEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- KEYS
- Stock Information
- Founded
- BNTX 2008
- KEYS 1939
- Country
- BNTX Germany
- KEYS United States
- Employees
- BNTX N/A
- KEYS N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- KEYS Industrial Machinery/Components
- Sector
- BNTX Health Care
- KEYS Industrials
- Exchange
- BNTX Nasdaq
- KEYS Nasdaq
- Market Cap
- BNTX 25.0B
- KEYS 25.9B
- IPO Year
- BNTX 2019
- KEYS N/A
- Fundamental
- Price
- BNTX $95.81
- KEYS $157.02
- Analyst Decision
- BNTX Strong Buy
- KEYS Buy
- Analyst Count
- BNTX 18
- KEYS 9
- Target Price
- BNTX $142.27
- KEYS $183.00
- AVG Volume (30 Days)
- BNTX 896.4K
- KEYS 1.1M
- Earning Date
- BNTX 05-05-2025
- KEYS 05-20-2025
- Dividend Yield
- BNTX N/A
- KEYS N/A
- EPS Growth
- BNTX N/A
- KEYS N/A
- EPS
- BNTX N/A
- KEYS 4.26
- Revenue
- BNTX $2,968,331,171.00
- KEYS $5,108,000,000.00
- Revenue This Year
- BNTX N/A
- KEYS $7.43
- Revenue Next Year
- BNTX $9.07
- KEYS $6.23
- P/E Ratio
- BNTX N/A
- KEYS $36.88
- Revenue Growth
- BNTX 0.61
- KEYS N/A
- 52 Week Low
- BNTX $76.53
- KEYS $119.72
- 52 Week High
- BNTX $131.49
- KEYS $186.20
- Technical
- Relative Strength Index (RSI)
- BNTX 46.34
- KEYS 52.42
- Support Level
- BNTX $96.38
- KEYS $157.85
- Resistance Level
- BNTX $100.48
- KEYS $162.79
- Average True Range (ATR)
- BNTX 3.44
- KEYS 3.46
- MACD
- BNTX 0.24
- KEYS -0.81
- Stochastic Oscillator
- BNTX 40.84
- KEYS 8.92
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About KEYS Keysight Technologies Inc.
Keysight Technologies is a leader in the field of testing and measurement, helping electronics OEMs and suppliers alike bring products to market to fit industry standards and specifications. Keysight specializes in the communications market, but also supplies into the government, automotive, industrial, and semiconductor manufacturing markets. Keysight's solutions include testing tools, analytical software, and services. The firm's stated objective is to reduce time to market and improve efficiency at its more than 30,000 customers.